Compare ELAN & KNSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELAN | KNSL |
|---|---|---|
| Founded | 1954 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 9.2B |
| IPO Year | 2018 | 2016 |
| Metric | ELAN | KNSL |
|---|---|---|
| Price | $23.27 | $374.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | $27.63 | ★ $455.40 |
| AVG Volume (30 Days) | ★ 4.2M | 261.3K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.26% |
| EPS Growth | N/A | ★ 21.77 |
| EPS | N/A | ★ 21.65 |
| Revenue | ★ $4,715,000,000.00 | $1,873,987,000.00 |
| Revenue This Year | $7.97 | $6.46 |
| Revenue Next Year | $5.21 | $8.77 |
| P/E Ratio | ★ N/A | $17.53 |
| Revenue Growth | 6.22 | ★ 18.04 |
| 52 Week Low | $8.02 | $341.06 |
| 52 Week High | $27.72 | $512.76 |
| Indicator | ELAN | KNSL |
|---|---|---|
| Relative Strength Index (RSI) | 37.77 | 42.10 |
| Support Level | $20.41 | $365.55 |
| Resistance Level | $23.70 | $402.61 |
| Average True Range (ATR) | 0.92 | 10.96 |
| MACD | -0.31 | -0.19 |
| Stochastic Oscillator | 7.20 | 17.54 |
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.